BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Sunday, June 14, 2026
Home » Topics » Briefs » Other news to note

Other news to note
Other news to note RSS Feed RSS

Other news to note for April 24, 2023

April 24, 2023
Additional early-stage research and drug discovery news in brief, from: Histogen, Rakovina Therapeutics.
Read More

Other news to note for April 21, 2023

April 21, 2023
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Active Implants, Aptitude Medical, Aziyo, Beacon Biomedical, Boehringer Ingelheim, Emit Imaging, Lemaitre Vascular, Neracare, Retinai, Skylinedx, Watkins-Conti.
Read More

Other news to note for April 21, 2023

April 21, 2023
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Boehringer Ingelheim, Emergent, Genmab, GRI, Janssen, Retinai, Vallon, Ventus.
Read More

Other news to note for April 21, 2023

April 21, 2023
Additional early-stage research and drug discovery news in brief, from: Locanabio.
Read More

Other news to note for April 20, 2023

April 20, 2023
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Abbott Laboratories, Cercare Medical, Concertai, Element Biosciences, Epic Sciences, Gemina, Grail, Illumina, Mdxhealth, Nvidia, Radimagenet, Readygo, Science 37, Segmed, Surmodics
Read More

Other news to note for April 20, 2023

April 20, 2023
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Amgen, Astellas, Blue Water, LG Chem, Moderna, Novartis, Sandoz, Senisca, Twist, Veru, Zydus.
Read More

Other news to note for April 20, 2023

April 20, 2023
Additional early-stage research and drug discovery news in brief, from: Inmune Bio, Vistagen Therapeutics.
Read More

Other news to note for April 19, 2023

April 19, 2023
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Ancora Heart, Angle, Bioview, Beyond Air, Beyond Cancer, Egnite, Exthera Medical, Fisher Healthcare, Seastar Medical, Senseonics, Thermo Fisher.
Read More

Other news to note for April 19, 2023

April 19, 2023
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Direct, Everest, Finch, Keyuan Xinhua, Maxion, Nona, Shanghai, Sinopia.
Read More

Other news to note for April 19, 2023

April 19, 2023
Additional early-stage research and drug discovery news in brief, from: Ascidian Therapeutics, Palatin Technologies.
Read More
Previous 1 2 … 183 184 185 186 187 188 189 190 191 … 1399 1400 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 12, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for June 9, 2026
  • Blood sample tubes after centrifuge

    Pre-disease plasma signature may help redefine lung cancer risk

    BioWorld
    Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
  • Purple molecules

    Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis

    BioWorld
    Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
  • Neck exam

    Ethyreal launches to treat the underlying cause of Graves’, TED

    BioWorld
    Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing